Related Experiment Videos
Ocufen and pupillary dilation during cataract surgery.
1Department of Ophthalmology, Washington University, St. Louis, Missouri.
Journal of Cataract and Refractive Surgery
|July 1, 1989
Summary
Ocufen (flurbiprofen) effectively maintained pupil dilation during cataract surgery, reducing constriction compared to standard regimens. This non-steroidal anti-inflammatory drug aids in maintaining optimal surgical conditions for extracapsular cataract extraction.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Maintaining adequate pupil dilation is crucial for successful cataract surgery.
- Pupil constriction during surgery can complicate extracapsular cataract extraction.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are sometimes used to aid pupil dilation.
Purpose of the Study:
- To evaluate the efficacy of Ocufen (flurbiprofen) in maintaining pupil dilation during elective extracapsular cataract extraction.
- To compare pupil diameter changes in patients receiving Ocufen versus a standard dilating regimen.
Main Methods:
- A randomized, masked, prospective study involving 100 patients undergoing cataract surgery.
- Standard dilating regimen administered to all patients; half received additional Ocufen drops.
- Pupil diameters measured via video recording at four key surgical stages.
Main Results:
- No statistically significant difference in preoperative pupil size between groups.
- Ocufen-treated patients demonstrated better average pupil dilation maintenance.
- A significantly lower incidence of pupil constriction (>2 mm) was observed in the Ocufen group.
Conclusions:
- Ocufen (flurbiprofen) is effective in maintaining pupil dilation during extracapsular cataract extraction.
- The use of Ocufen can reduce intraoperative miosis, potentially improving surgical outcomes.
- Flurbiprofen represents a valuable adjunct for optimizing pupil dynamics in cataract surgery.